Early-stage companies need to make things happen fast: Move from seed funding to Series-level investment. Transition from bench test to clinical trials. Or support strategic initiatives in key market segments. It all boils down to doing a shortlist of critical things fast, economically, and on target.
We are found on the front lines of these projects handling branding, public relations, and communications for investment opportunities, technology development, and acquisition.
We have proven our value in simplifying science-based companies’ messages for both the investment community and the press. Our media relations engine spread those vital messages in healthcare journals and business press to attract patients, physicians, and investors to companies and their platforms.
Especially in times of great uncertainty, our ability to clearly cut through distraction to attract the right kind of attention from the trade press, financial circles, and influential leaders in the healthcare industry, makes your business have a greater shot at receiving the attention and valuation it needs to thrive.